-
Je něco špatně v tomto záznamu ?
Socioeconomic variations determine the clinical presentation, aetiology, and outcome of infective endocarditis: a prospective cohort study from the ESC-EORP EURO-ENDO (European Infective Endocarditis) registry
SP. Sengupta, B. Prendergast, C. Laroche, S. Furnaz, R. Ronderos, A. Almaghraby, FM. Asch, K. Blechova, H. Zaky, J. Strahilevitz, R. Dworakowski, Y. Miyasaka, I. Sebag, C. Izumi, O. Axler, A. Jamiel, M. Philip, ML. Campos Vieira, P. Lancellotti, G. Habib
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články
NLK
ProQuest Central
od 2016-10-01 do Před 1 rokem
Health & Medicine (ProQuest)
od 2016-10-01 do Před 1 rokem
PubMed
35278091
DOI
10.1093/ehjqcco/qcac012
Knihovny.cz E-zdroje
- MeSH
- bakteriální endokarditida * komplikace diagnóza epidemiologie MeSH
- dospělí MeSH
- endokarditida * diagnóza epidemiologie etiologie MeSH
- lidé MeSH
- prospektivní studie MeSH
- registrace MeSH
- srdeční selhání * MeSH
- Check Tag
- dospělí MeSH
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
AIMS: Infective endocarditis (IE) is a life-threatening disease associated with high mortality and morbidity worldwide. We sought to determine how socioeconomic factors might influence its epidemiology, clinical presentation, investigation and management, and outcome, in a large international multicentre registry. METHODS AND RESULTS: The EurObservational Programme (EORP) of the European Society of Cardiology EURO-ENDO (European Infective Endocarditis) registry comprises a prospective cohort of 3113 adult patients admitted for IE in 156 hospitals in 40 countries between January 2016 and March 2018. Patients were separated in three groups, according to World Bank economic stratification [group 1: high income (75.6%); group 2: upper-middle income (15.4%); group 3: lower-middle income (9.1%)]. Group 3 patients were younger [median age (interquartile range, IQR): group 1, 66 (53-75) years; group 2, 57 (41-68) years; group 3, 33 (26-43) years; P < 0.001] with a higher frequency of smokers, intravenous drug use, and human immunodeficiency virus infection (all P < 0.001) and presented later [median (IQR) days since symptom onset: group 1, 12 (3-35); group 2, 19 (6-54); group 3, 31 (12-62); P < 0.001] with a higher likelihood of developing congestive heart failure (13.6%, 11.1%, and 22.6%, respectively; P < 0.001) and persistent fever (9.8%, 14.2%, and 27.9%, respectively; P < 0.001). Among 2157 (69.3%) patients with theoretical indication for cardiac surgery, surgery was performed less frequently in group 3 patients (75.5%, 76.8%, and 51.3%, respectively; P < 0.001), who also demonstrated the highest mortality (15.0%, 23.0%, and 23.7%, respectively; P < 0.001). CONCLUSION: Socioeconomic factors influence the clinical profile of patients presenting with IE across the world. Despite younger age, patients from the poorest countries presented with more frequent complications and higher mortality associated with delayed diagnosis and lower use of surgery.
Aix Marseille Univ IRD APHM MEPHI IHU Méditerranée Infection Marseille France
Cardiac Imaging Department ICBA Instituto Cardiovascular Buenos Aires Argentina
Cardiology and Angiology Department University of Alexandria Alexandria Egypt
Cardiology Department CHU Timone Marseille France
Cardiovascular Core Labs MedStar Health Research Institute Washington DC USA
Cardiovascular Division Department of Medicine 2 Kansai Medical University Osaka Japan
Department of Cardiac Surgery Hospital Na Homolce Prague Czech Republic
Department of Cardiology Dubai Hospital Dubai UAE
Department of Cardiology King's College Hospital London UK
Department of Cardiology St Thomas' Hospital London UK
Department of Research National Institute of Cardiovascular Diseases Karachi Pakistan
EurObservational Programme European Society of Cardiology Sophia Antipolis France
Gruppo Villa Maria Care and Research Maria Cecilia Hospital Cotignola and Anthea Hospital Bari Italy
Jewish General Hospital Montreal Canada
National Cerebral and Cardiovascular Center 6 1 Kishibe Shinmachi Suita Osaka Japan
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22032191
- 003
- CZ-PrNML
- 005
- 20230131151752.0
- 007
- ta
- 008
- 230120s2022 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1093/ehjqcco/qcac012 $2 doi
- 035 __
- $a (PubMed)35278091
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Sengupta, Shantanu P $u Department of Cardiology, Sengupta Hospital and Research Institute, Ravinagar Square, Ravinagar, Nagpur 440033, India $1 https://orcid.org/0000000205779274
- 245 10
- $a Socioeconomic variations determine the clinical presentation, aetiology, and outcome of infective endocarditis: a prospective cohort study from the ESC-EORP EURO-ENDO (European Infective Endocarditis) registry / $c SP. Sengupta, B. Prendergast, C. Laroche, S. Furnaz, R. Ronderos, A. Almaghraby, FM. Asch, K. Blechova, H. Zaky, J. Strahilevitz, R. Dworakowski, Y. Miyasaka, I. Sebag, C. Izumi, O. Axler, A. Jamiel, M. Philip, ML. Campos Vieira, P. Lancellotti, G. Habib
- 520 9_
- $a AIMS: Infective endocarditis (IE) is a life-threatening disease associated with high mortality and morbidity worldwide. We sought to determine how socioeconomic factors might influence its epidemiology, clinical presentation, investigation and management, and outcome, in a large international multicentre registry. METHODS AND RESULTS: The EurObservational Programme (EORP) of the European Society of Cardiology EURO-ENDO (European Infective Endocarditis) registry comprises a prospective cohort of 3113 adult patients admitted for IE in 156 hospitals in 40 countries between January 2016 and March 2018. Patients were separated in three groups, according to World Bank economic stratification [group 1: high income (75.6%); group 2: upper-middle income (15.4%); group 3: lower-middle income (9.1%)]. Group 3 patients were younger [median age (interquartile range, IQR): group 1, 66 (53-75) years; group 2, 57 (41-68) years; group 3, 33 (26-43) years; P < 0.001] with a higher frequency of smokers, intravenous drug use, and human immunodeficiency virus infection (all P < 0.001) and presented later [median (IQR) days since symptom onset: group 1, 12 (3-35); group 2, 19 (6-54); group 3, 31 (12-62); P < 0.001] with a higher likelihood of developing congestive heart failure (13.6%, 11.1%, and 22.6%, respectively; P < 0.001) and persistent fever (9.8%, 14.2%, and 27.9%, respectively; P < 0.001). Among 2157 (69.3%) patients with theoretical indication for cardiac surgery, surgery was performed less frequently in group 3 patients (75.5%, 76.8%, and 51.3%, respectively; P < 0.001), who also demonstrated the highest mortality (15.0%, 23.0%, and 23.7%, respectively; P < 0.001). CONCLUSION: Socioeconomic factors influence the clinical profile of patients presenting with IE across the world. Despite younger age, patients from the poorest countries presented with more frequent complications and higher mortality associated with delayed diagnosis and lower use of surgery.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a prospektivní studie $7 D011446
- 650 12
- $a endokarditida $x diagnóza $x epidemiologie $x etiologie $7 D004696
- 650 12
- $a bakteriální endokarditida $x komplikace $x diagnóza $x epidemiologie $7 D004697
- 650 _2
- $a registrace $7 D012042
- 650 12
- $a srdeční selhání $7 D006333
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Prendergast, Bernard $u Department of Cardiology, St Thomas' Hospital, London, UK $1 https://orcid.org/0000000260312124
- 700 1_
- $a Laroche, Cécile $u EurObservational Programme, European Society of Cardiology, Sophia Antipolis, France
- 700 1_
- $a Furnaz, Shumaila $u Department of Research, National Institute of Cardiovascular Diseases, Karachi, Pakistan
- 700 1_
- $a Ronderos, Ricardo $u Cardiac Imaging Department, ICBA Instituto Cardiovascular, Buenos Aires, Argentina
- 700 1_
- $a Almaghraby, Abdallah $u Cardiology and Angiology Department, University of Alexandria, Alexandria, Egypt
- 700 1_
- $a Asch, Federico M $u Cardiovascular Core Labs, MedStar Health Research Institute, Washington, DC, USA
- 700 1_
- $a Blechova, Kamila $u Department of Cardiac Surgery, Hospital Na Homolce, Prague, Czech Republic
- 700 1_
- $a Zaky, Hosam $u Department of Cardiology, Dubai Hospital, Dubai, UAE
- 700 1_
- $a Strahilevitz, Jacob $u Department of Clinical Microbiology and Infectious Diseases, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
- 700 1_
- $a Dworakowski, Rafal $u Department of Cardiology, King's College Hospital, London, UK
- 700 1_
- $a Miyasaka, Yoko $u Cardiovascular Division, Department of Medicine II, Kansai Medical University, Osaka, Japan
- 700 1_
- $a Sebag, Igal $u Jewish General Hospital, Montreal, Canada
- 700 1_
- $a Izumi, Chisato $u National Cerebral and Cardiovascular Center, 6-1 Kishibe-Shinmachi, Suita, Osaka, Japan
- 700 1_
- $a Axler, Olivier $u Department of Cardiology, Centre Hospitalier Territorial Gaston Bourret Médipôle Dumbéa, New Caledonia, France
- 700 1_
- $a Jamiel, Abdulrahman $u King Saud bin Abadulaziz University for Health Specialities, Ministry of National Guard, Riyadh, Saudi Arabia
- 700 1_
- $a Philip, Mary $u Cardiology Department, CHU, Timone, Marseille, France
- 700 1_
- $a Campos Vieira, Marcelo Luiz $u Hospital Israelita Albert Einstein, and Incor, Heart Institute, São Paulo University Medical Schiool, São Paulo, Brazil
- 700 1_
- $a Lancellotti, Patrizio $u GIGA Cardiovascular Sciences, Department of Cardiology and Cardiovascular Surgery, University of Liège Hospital, CHU SartTilman, Liège, Belgium $u Gruppo Villa Maria Care and Research, Maria Cecilia Hospital, Cotignola, and Anthea Hospital, Bari, Italy
- 700 1_
- $a Habib, Gilbert $u Cardiology Department, CHU, Timone, Marseille, France $u Aix Marseille Univ, IRD, APHM, MEPHI, IHU-Méditerranée Infection, Marseille, France $1 https://orcid.org/0000000338999983
- 773 0_
- $w MED00200141 $t European heart journal. Quality of care & clinical outcomes $x 2058-1742 $g Roč. 9, č. 1 (2022), s. 85-96
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/35278091 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230120 $b ABA008
- 991 __
- $a 20230131151747 $b ABA008
- 999 __
- $a ok $b bmc $g 1891134 $s 1183526
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2022 $b 9 $c 1 $d 85-96 $e 2022Dec13 $i 2058-1742 $m European heart journal. Quality of care & clinical outcomes $n Eur Heart J Qual Care Clin Outcomes $x MED00200141
- LZP __
- $a Pubmed-20230120
